Curing Alzheimer’s: Use of microbubbles and ultrasound to increase blood brain barrier permeability for drug delivery Elizabeth Lee, Sam Covaia, and Katie Rodeghiero
Alzheimer’s disease is a neurodegenerative disorder that is estimated to affect over 6 million Americans. The disease is marked by the presence of plaques and tangles in the brain. While some trials have hoped to combat these plaques using antibodies, the semipermeable blood brain barrier (BBB) blocks their passage. In order to get antibodies across